Featured White Papers
- Oct. 14th: Simplified IT with Software-as-a-Service (SaaS) (ZDNet)
- PCI DSS therapy for the smaller retailer (McAfee)
- Recognizing the benefits of telework (Citrix Online)
Health Care Industry
Industry: Email Alert RSS FeedBurkholderia cenocepacia vaginal infection in patient with smoldering myeloma and chronic hepatitis C
Emerging Infectious Diseases, Nov, 2004 by Andrea Petrucca, Paola Cipriani, Rosa Sessa, Antonella Teggi, Rosalia Pustorino, Daniela Santapaola, Mauro Nicoletti
References
(1.) Gillan PH, Whittier S. Burkholderia, Stenotrophomonas, Ralstonia, Brevundimonas, Comamonas and Acidovorax In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolker RH, editors. Manual of clinical microbiology. Washington: American Society of Microbiolgy; 1999. p. 526-38.
(2.) Coenye T, Vandamme P. Diversity and significance of Burkholderia species occupying diverse ecological niches. Environ Microbiol. 2003;5:719-29.
(3.) Coenye T, LiPuma JJ. Molecular epidemiology of Burkholderia species. Front Biosci. 2003;8:e55-67.
(4.) Vandamme P, Holmes B, Coenye T, Goris J, Mahenthiralingam E, LiPuma JJ, Govan JRW. Burkholderia cenocepacia sp. nov.--a new twist to an old story. Res Microbiol. 2003;154:91-6.
(5.) Speert DP, Henry DA, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis. 2002;8:181-7.
(6.) Agodi A, Mahenthiralingam E, Bachitta M, Giannino V, Sciacca A, Stefani S. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J Clin Microbiol. 2001:39:2891-6.
(7.) LiPuma JJ, Spilker T, Gill GH, Campbell PW, Liu L, Mahenthiralingam E. Disproportionate distribuition of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Resp Crit Care Med. 2001;164:92-6.
(8.) Coenye T, Vandamme P, Govan JRW, LiPuma JJ. Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol. 2001;39:3427-36.
(9.) Nzula S, Vandamme P, Govan JR. Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex. J Antimicrob Chemother. 2002;50:265-9.
(10.) Henry DA, Mahenthiralingam E, Vandamme P, Coenye T, Speert DP. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J Clin Microbiol. 2001;39:1073-8.
(11.) Vandamme P, Henry D, Coenye T, Nzula S, Vancanneyt M, LiPuma JJ, et al. Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. FEMS Immunol Med Microbiol. 2002;33:143-9.
(12.) Vermis K, Coenye T, Mahenthiralingam E, Nelis HJ, Vandamme P. Evaluation of species-specific recA-based PCR tests for genomovar level identification within the Burkholderia cepacia complex. J Med Microbiol. 2002;51:937-40.
(13.) Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, et al. DNA-based diagnostic approaches for the identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis. Burkholderia cepacia genomovars I and III. J Clin Microbiol. 2000;38:3165-73.
(14.) Petrucca A, Cipriani P, Valenti P, Santapaola D, Cimmino C, Scoarughi GL, et al. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center. Res Microbiol. 2003;154:491-8.